DGX vs ECL · P/E 22, rev $9.87B vs P/E 35, rev $4.01B
Quest Diagnostics Incorporated (DGX) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported DGX revenue for 2024-12-31 was $9.87B. Net income was $921.0M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the DGX and ECL stock pages for the full models.
Not investment advice.